Evidence for cell autonomous AP1 function in regulation of Drosophila motor-neuron plasticity by Sanyal, Subhabrata et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Neuroscience
Open Access Research article
Evidence for cell autonomous AP1 function in regulation of 
Drosophila motor-neuron plasticity
Subhabrata Sanyal*1, Radhakrishnan Narayanan1, Christos Consoulas2 and 
Mani Ramaswami*1,3
Address: 1Department of Molecular & Cellular Biology, Box 210106 University of Arizona, 1007 E. Lowell Street, Tucson AZ 85721, USA, 
2Department of Experimental Physiology, Medical School, University of Athens, Athens, Greece and 3ARL Division of Neurobiology, University 
of Arizona, Tucson AZ 85721, USA
Email: Subhabrata Sanyal* - sanyal@u.arizona.edu; Radhakrishnan Narayanan - rnarayan@u.arizona.edu; 
Christos Consoulas - cconsoul@med.uoa.gr; Mani Ramaswami* - mani@u.arizona.edu
* Corresponding authors    
Abstract
Background:  The transcription factor AP1 mediates long-term plasticity in vertebrate and
invertebrate central nervous systems. Recent studies of activity-induced synaptic change indicate
that AP1 can function upstream of CREB to regulate both CREB-dependent enhancement of
synaptic strength as well as CREB-independent increase in bouton number at the Drosophila
neuromuscular junction (NMJ). However, it is not clear from this study if AP1 functions
autonomously in motor neurons to directly modulate plasticity.
Results: Here, we show that Fos and Jun, the two components of AP1, are abundantly expressed
in motor neurons. We further combine immunohistochemical and electrophysiological analyses
with use of a collection of enhancers that tightly restrict AP1 transgene expression within the
nervous system to show that AP1 induction or inhibition in, but not outside of, motor neurons is
necessary and sufficient for its modulation of NMJ size and strength.
Conclusion: By arguing against the possibility that AP1 effects at the NMJ occur via a polysynaptic
mechanism, these observations support a model in which AP1 directly modulates NMJ plasticity
processes through a cell autonomous pathway in the motor neuron. The approach described here
may serve as a useful experimental paradigm for analyzing cell autonomy of genes found to influence
structure and function of Drosophila motor neurons.
Background
Long-term forms of synaptic plasticity are distinguished
from transient short-term forms by a requirement for new
gene expression [1]. The nature of the transcriptional
switch that interprets and responds to synaptic signals
that trigger persistent changes to synapses, remains
intensely studied but yet poorly established. In the con-
sensus model, ERK-dependent phosphorylation of CREB
initiates CREB-dependent transcription of a first wave of
immediate early genes including transcription factors
such as Fos and Jun that dimerize to form AP1. Immedi-
ate-early transcription-factors, either independently or in
collaboration with CREB, then regulate waves of gene
expression that underlie persistent changes in synaptic
strength and architecture. Such a model is supported by
dramatic demonstrations of the effects of CREB activation
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on enhancing forms of long-term memory [2,3] and syn-
aptic plasticity [4,5].
The generality of the CREB-switch model has been specif-
ically questioned by two previous studies at the Drosophila
motor synapse. These studies indicate that CREB is dis-
pensable for the activity-dependent modulation of bou-
ton number at the Drosophila larval NMJ [6], a process that
shares compelling mechanistic similarities to morpholog-
ical changes required for long-term facilitation in Aplysia.
Because activity-induced synaptic growth in Aplysia
requires new neuronal gene expression [7], it was likely
that a yet-to-be-identified transcription factor acted to
control a CREB-independent gene expression module
required for synaptic growth. A recent study suggests that
this transcription factor may be AP1 [8], a transcription
factor previously shown to be CREB responsive [9–11],
essential for some forms of long-term memory [12,13],
and for long-term cocaine sensitization [14]. This recent
analysis shows that AP1 activity in the Drosophila CNS,
under regulation by endogenous JNK signalling, regulates
both bouton number and synaptic strength at the larval
motor synapse. AP1-mediated synaptic growth occurs
through a mechanism independent of CREB; however,
AP1-mediated increase in synaptic strength (evoked trans-
mitter release) requires CREB. Increased levels of CREB
mRNA detected in heads of Drosophila after a brief induc-
tion of AP1, suggested that AP1 may act upstream of CREB
and that AP1 activation may be sufficient to induced
CREB dependent and CREB-independent aspects of plas-
ticity [8].
While provocative, these analyses did not exclude the pos-
sibility that AP1 expression in modulatory neurons affect
motor synapse plasticity by trans-synaptic signalling
mechanisms. Here we present a detailed analysis of the
cell autonomy of AP1 functions. Using well characterized
markers for motor neurons, and previously reported
motor-neuron restricted enhancers carefully documented
here, we present new lines of evidence in support of a
model in which AP1 functions in the motor neuron and
regulates NMJ plasticity via its effects on gene expression
in the motor neuron.
Results
Fos and Jun are expressed in motor neurons
For AP1 to function in motor neurons, both of its constit-
uent subunits, Fos and Jun, must be expressed in these
cells. We localized the proteins to motor neurons relative
to specific markers.
The X-chromosomal C380  enhancer in particular has
been reported, based on unpublished observations, to
specifically mark embryonic and larval motor neurons
[15–17]. To confirm and document the expression pattern
of this enhancer, we visualized cells in the Drosophila CNS
labelled by C380 driven nuclear green fluorescent protein
(NlsGFP). In the ventral ganglion of III instar larvae C380
appeared highly selective in expression, marking only a
subset of cells per hemisegment cells from a large field of
neurons identified using the pan-neuronal marker Elav
(Figures 1A,1B and 1C). In the medial, dorsal surface of
the ganglion, that contains identified RP and aCC motor
neurons [18], C380 drives GFP reporter expression in 5 of
6 neurons that could be detected in each hemisegment
(the neuron not labelled by C380 is indicated by an aster-
isk in Figure 1C). Away from this medial zone, in the lat-
eral zones, several cells marked by C380  appeared
negative for Elav staining (Figures 1A,1B and 1C).
We positively identified all 5 medial, C380-expressing
cells as motor neurons using two lines of evidence. First,
the aCC (arrow in Figure 1C) and RP2 (arrowhead in Fig-
ure 1C) motor neurons identified by anti-Eve staining
[17] were among the 5 C380 expressing neurons (data not
shown). Second, and more conclusively, Rhodamine-dex-
tran backfills of the entire peripheral nerve bundle
(including both the ISN and SN) that innervates abdomi-
nal segment A6 clearly marked 5 medial motor neurons
per hemisegment. Of the three contralateral MNs, two are
RP3 and RP5; the two ipsilateral ones are aCC and RP2
[18,19]. In double "stained" preparations, these same 5
cells are also marked by C380 reporter expression (Figure
1D). C380 driven soluble GFP, beautifully labelled presy-
naptic nerve terminals on the larval body wall muscle fur-
ther confirming expression in the large majority of motor
neurons in the central nervous system (Figure 1L).
To assess the time at which C380 expression starts, we
stained C380-GAL4; UAS-NGFP embryos at various stages
with anti-elav to mark differentiated neurons (Figure 1K).
GFP expression in the CNS starts at very late stages
(beyond stage 17, data not shown) in embryogenesis and
there is no discernible GFP expression even at stage 15 by
which time motor neuron differentiation has already
taken place. This suggests that in our experiments, AP1
activation or inhibition in differentiated motor neurons is
sufficient to cause changes at their synapses. To further
test if C380 expression in embryonic stages or earlier lar-
val instars occurs transiently in a broader domain, we did
the following experiment. C380; UAS-cd8GFP males were
crossed to virgin females containing UAS-FLP and actin-
FRT-raf-FRT-n lacZ. In the progeny, cd8-GFP would report
current C380 expression. On the other hand, any cell that
has seen significant GAL4 expression during the develop-
ment of the animal, would express the flippase recombi-
nase. In such a cell, the stuffer raf fragment would be
excised out using the flanking FRT sites, leading to
nuclear-lacZ expression from the actin promoter [20]. Fig-
ure 1M shows the general expression of nlacZ in a thirdBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
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Fos and Jun are expressed in motor neurons marked by the C380 enhancer Figure 1
Fos and Jun are expressed in motor neurons marked by the C380 enhancer. In third-instar larval ventral ganglia, 
C380 enhancer-driven nuclear GFP (A) marks the dorso-medial cells labelled with the neuronal marker Elav (B and C) and (D) 
by retrograde fills of the motor nerve (cells circled by a yellow line; cells with a green boundary represent the complementary 
neurons on the adjoining hemisegment). An arrowhead marks RP2 and an arrow marks aCC in 1C. An asterisk marks a dorsal 
medial neuron not labelled by C380. Both Fos (F) and Jun (I) are expressed strongly in medial motor neurons marked by the 
C380 enhancer (E and H). Figure 1G and 1J are merged images of the above showing Fos and Jun expression in identified C380 
positive motor neurons. Fos and Jun are also expressed at lower levels in other neurons and non-neuronal cells including CNS 
glia (not shown). 1K shows a stage 15 embryo expressing C380-Nls-GFP (green) counterstained with anti-elav (red) to mark all 
differentiated neurons. GFP expression is only seen in PNS neurons (arrowhead) and in salivary gland (asterisk). C380 driven 
GFP can be detected at high levels at motor synapses in the third instar larva such as that on muscles 6 and 7 (L). The synapse 
is counterstained with anti-synaptotagmin to mark synaptic boutons (arrowhead). Figure 1M shows a third instar ventral gan-
glion stained for nuclear lacZ. This expression pattern closely mimics that of C380-GAL4. In this animal, lacZ is expressed from 
an actin promoter only in cells in which "flip-out" of a stuffer DNA has occurred due to C380-GAL4 driven UAS-FLP. Figure 
1N shows C380 driven membrane bound cd8-GFP expression in the dorsal medial region of a third instar ventral ganglion. 1O 
shows n-lacZ in the same animal and 1P is a merged image showing that n-lacZ is expressed only in the motor neurons that are 
also positive for C380 expression at this developmental stage. The specificity of the Fos antibodies is shown by increased 
immunoreactivity in motor neurons when AP1 is expressed under control of the C380 enhancer (Q and R). The dashed yellow 
lines in all cases approximately mark the midline.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
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instar ventral ganglion from such an animal. This expres-
sion pattern, a memory of GAL4 expression through
development, is highly reminiscent of the C380 profile.
Figure 1N,1O and 1P show a close-up of the dorsal medial
region. All motor neurons that are labelled with cd8-GFP
also have strong nlacZ labelling. Taken together, these
results strongly suggest that the C380 expression in motor
neurons occurs after their differentiation and in a profile
that is stable through development.
Using affinity-purified antibodies against the respective
proteins [21], we discovered strong expression of Fos and
Jun in dorsal motor neuron clusters marked by C380
expression (Figures 1E,1F,1G,1H,1I,1J). While the
The OK6 enhancer is predominantly restricted to motor neurons while the Cha (cholineacetyltransferase) enhancer is largely  excluded from these cells Figure 2
The OK6 enhancer is predominantly restricted to motor neurons while the Cha (cholineacetyltransferase) 
enhancer is largely excluded from these cells. Images of ventral ganglia double labelled to reveal OK6 enhancer driven 
nuclear GFP (A) and Elav-expressing neurons (B). Similar images of ventral ganglia processed to compare Cha-driven n GFP (D) 
with Elav-labelled neurons (E). Cha-GAL4 expression in aCC neurons is shown by an arrowhead in 2D, E and F. Neuromuscu-
lar junctions (muscles 6 and 7) of animals expressing GFP under OK6 control show strongly fluorescent motor terminals (G). 
Figure 2H shows a stage 15 embryo expressing nuclear GFP driven by OK6-GAL4, counterstained with anti-elav to mark all 
differentiated neurons. GFP expression is only seen in salivary gland (asterisk) and some non-neuronal cells (arrowhead).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
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proteins were also found in most other neurons and in
glia, expression in motor neurons was particularly strong.
The specificity of the antibody and the effectiveness of
C380 in driving Fos and Jun expression are both demon-
strated by dramatically increased Fos and Jun immunore-
activity in neurons of flies overexpressing AP1 (eg. Figures
1Q and 1R). Thus, Fos and Jun are well positioned for
autonomous function in presynaptic plasticity of the Dro-
sophila NMJ.
Other enhancers that mark or exclude Drosophila larval 
motor neurons
In addition to C380 at least two other enhancers have
value for restricting transgene expression to (or excluding
expression from) motor neurons (Figure 2). The OK6
enhancer line has been recently reported to be motor neu-
ron specific [22]. In contrast, the recently mapped cholin-
eacetyltransferase (Cha) promoter labels cholinergic
neurons and may be expected to exclude motor neurons
[23,24]. Relatively strong expression of this enhancer in
the nervous system is argued by the observation that it
causes a strong loss-of-function phenotype when used to
drive a dominant-negative shibirets  transgene [25]. We
used methods similar to those used for analysis of C380 to
confirm the expected patterns of expression for these
enhancers.
OK6  driven green nuclear fluorescent protein (GFP)
labelled medial motor neurons previously identified with
C380 (Figures 2A,2B and 2C); the identification of these
cells was unambiguous. However, motor neuron expres-
sion was further confirmed by strong labelling of motor
terminals by OK6 driven GFP marker (Figure 2G). OK6
expression in the rest of the ventral ganglion appeared dis-
tinct from and sparser than that observed with C380 (Fig-
ures 2A,2B,2C). In these animals, similar to C380,
expression does not start until very late in embryogenesis.
Figure 2H shows a stage 15 embryo expressing NGFP
driven by OK6-GAL4, counterstained with anti-elav. Apart
from expression in the salivary gland (asterisk) and some
non-neuronal cells (arrowhead) expression of GFP in the
CNS is completely absent. In contrast to OK6, the Cha
promoter predominantly labelled cells in the lateral
region of the ventral ganglion (Figure 2D,2E and 2F).
Additional expression was observed in two neurons in the
region of the medial motor neuron cluster. One of these is
aCC as it is marked by anti-eve antibodies and is also
labelled by backfills from motor axon bundles (data not
shown). The other neuron is most likely an interneuron as
it is not labelled by the backfill and is also excluded from
C380-nlsGFP expressing ganglia. Additionally, Cha-
driven GFP did not label motor terminals on muscles 6
and 7 (data not shown) indicating that even if it were
expressed in some motor neurons, it was excluded from
the motor neurons innervating ventral longitudinal
muscles.
Together, these analyses of C380, OK6 and Cha expression
allow us to reach the following conclusions. First, C380
and OK6 are each expressed in a small fraction of neurons
in the CNS. Both C380 and OK6 are expressed in larval
motor neurons, particularly in those that innervate the
ventral longitudinal muscles 6 and 7. Secondary expres-
sion in non-motor neurons, not excluded by our analyses,
appears to be both limited and largely non-overlapping
between C380 and OK6. The Cha promoter on the other
hand is not expressed in the vast majority of motor neu-
rons but nevertheless is strongly expressed in a significant
fraction of the central nervous system.
Perturbation of AP1 in motor neurons regulates NMJ 
plasticity
Previous analyses showing that pan-neural perturbations
of AP1 influence both motor synapse number and
strength, do not rule out the possibility that the observed
effects of this transcription factor on motor neuron plas-
ticity occur via a polysynaptic pathway. If AP1's effects on
presynaptic plasticity were cell autonomous, then these
effects should be observed by AP1 perturbation specifi-
cally in motor neurons but not following similar pertur-
bation of AP1 function outside of these cells.
Our analysis of changes in bouton number and evoked
transmitter release induced by C380-driven or OK6-driven
dominant AP1-transgenes is completely consistent with
cell autonomous effects (Figure 3A,3B, Table 1). C380-
driven Fos inhibitor (FBZ) reduces synaptic strength to
about 50+/-7% and bouton number to 75+/-3% of con-
trol animals. Thus, AP1 activity is required in C380 posi-
tive cells for normal developmental plasticity. More
striking,  C380-driven wild-type AP1 increases synaptic
strength to 143+/-12% and bouton number to 123+/-5%
of control. These results, significant to better than 99%
confidence, are comparable to or, in some cases, more
robust than, what we have previously reported for effects
of pan-neural, elav (C155) enhancer driven expression of
these same AP1-perturbing transgenes [8]. The conclusion
from this experiment, that AP1 functions autonomously
in motor neurons to regulate both structural and func-
tional aspects of presynaptic plasticity is limited only by
potentially important contributions of AP1 perturbation
in C380 expressing cells that are not motor neurons.
To address this caveat, we analyzed effects of OK6 driven,
AP1-perturbing transgenes on motor synapse plasticity.
Results from these experiments were completely consist-
ent with predictions based on the analysis of C380. OK6-
driven FBZ expression resulted in a mean EJC amplitude
55+/-4% and a synapse size 63+/3% of wild type. OK6-BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
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AP1 effects on NMJ plasticity are tightly correlated with motor neuron expression Figure 3
AP1 effects on NMJ plasticity are tightly correlated with motor neuron expression. Upper panel shows the effect 
of inhibition or activation of AP1 in motor neurons using two different motor-neuron GAL4 drivers, C380 and OK6. Repre-
sentative EJC traces are also shown to highlight the contrasting results of AP1 inhibition or activation. The lower panel shows 
that similar manipulations in either non-motor neurons (ChaGAL4) or post-synaptic muscle (MHCGAL4) has minimal effects on 
synaptic plasticity. Dotted lines represent control levels (for actual values see Table 1). Scale bar: X-axis = 20 msec and Y-axis 
= 20 nA.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
Page 7 of 10
(page number not for citation purposes)
driven AP1 expression caused the expected increase in size
and strength (EJC was 119+/-7% and synapse size 114+/-
5% of wild type).
The relatively mild effect that OK6-driven AP1 has on syn-
apse growth and strength may be explained by lower activ-
ity of the OK6  enhancer. However, the effect is
unequivocal (p < 0.006 for synapse size and <0.01 for
EJC) and consistent with analysis of C380 driven or pan-
neural expression of AP1.
AP1 perturbation in cholinergic neurons or in muscle does 
not alter the NMJ
We performed additional experiments to confirm that
induction of AP1 perturbing transgenes in cholinergic
CNS neurons did not alter synapse size or strength at the
NMJs on muscles 6 and 7 (Figure 3C, Table 1). ChaGal4
driven AP1 inhibitory and inducing transgenes had no
effect on bouton number or synaptic strength at the larval
nmj. In percent of control, values of synaptic strength and
bouton number for ChaGal4 FBZ are 99+/-4% and 90+/-
8%, and for ChaGal4 AP1, 98+/-5% and 97+/-7%, respec-
tively. We had previously reported, based on unpublished
observations, that postsynaptic expression of AP1 modu-
lating transgenes did not alter motor neuron plasticity [8].
Results for consequences of expressing FBZ or AP1 in mus-
cle through the Myosin Heavy Chain enhancers are shown
in Figure 3D and Table 1. Muscle expression of FBZ
resulted in bouton number and EJC amplitudes of 113+/-
5% and 102+/-4%, statistically indistinguishable from the
control NMJs. Similarly, muscle expression of AP1 gave
values of 92+/-4% for bouton number and 93+/-4% for
EJCs. These results further restrict the range of cells in
which AP1 must function in order to influence motor syn-
apse plasticity.
Discussion
While the role of neural activity, cAMP, adenylate cyclase,
ERK, CREB and AP1 in Drosophila NMJ plasticity has been
extensively analyzed [6,8,16,26,27], the cells in which
these regulatory molecules must function for synaptic
plasticity have generally not been clearly identified. Here,
using an approach that could be usefully adapted for
analysis of other components of synaptic plasticity, we
provide a compelling argument for a model in which AP1
functions cell autonomously in motor neurons to regulate
NMJ plasticity in Drosophila.
Caveats to this conclusion derive from uncertainties
intrinsic to the use of specific neuronal enhancers to
address issue of tissue or cell specificity. Our analyses of
the expression patterns of two enhancers unambiguously
establish several important points. Both C380 and OK6
are highly expressed in motor neurons [16,17,22]. Sec-
ondary expression of these enhancers outside of motor
neurons, if present, is first limited and second quite differ-
ent for the two enhancers (Figures 1 and 2). Thus, com-
mon phenotypes caused when AP1 transgenes are
expressed by either OK6 or C380 likely result from expres-
sion in the neurons positive for both enhancers, i.e. the
motor neurons.
It is necessary to acknowledge that our analyses of the
expression patterns for C380 and OK6, being confined to
the III instar larval stage, do not in themselves rule out the
possibility that these enhancers are transiently turned on,
Table 1: AP1 effects at the larval neuromuscular junction derive from its action in motor neurons. GAL4 drivers that include expression 
in motor neurons (C155, C380 and OK6) alter synaptic plasticity through either inhibition (FBZ) or activation (AP1) of AP1. Non-motor 
neuron drivers (Cha) or post-synaptic muscle drivers (MHC) do not achieve this effect. All numbers are raw values (+/- SEM). Numbers 
in the top left corner of each box are number of animals analyzed in each case. Numbers for C155 are reproduced from Sanyal et al., 
2002. Abbreviations: EJC stands for evoked junctional current amplitude, mEJC for miniature evoked junctional current amplitude, and 
QC is quantal content of the evoked response.
C155 C380 OK6 Cha MHC
Control (9) (11) (7) (10) (6)
EJC 108 +/-6 85 +/-3 139 +/-6 90 +/-6 100 +/-8
mEJC 0.76 +/-0.02 0.70 +/-0.03 0.8 +/-0.08 0.75 +/-0.06 0.89 +/-0.05
QC 142 +/-9 122 +/-8 183 +/-16 129 +/-15 115 +/-11
FBZ (7) (10) (6) (9) (7)
EJC 80 +/-4 42 +/-6 77 +/-6 79 +/-8 102 +/-4
mEJC 0.78 +/-0.04 0.76 +/-0.05 0.66 +/-0.07 0.89 +/-0.09 0.85 +/-0.03
QC 103 +/-7 56 +/-3 120 +/-11 91 +/-8 122 +/-8
AP1 (9) (14) (10) (10) (9)
EJC 146 +/-6 121 +/-10 166 +/-11 87 +/-6 91 +/-4
mEJC 0.69 +/-0.05 0.6 +/-0.05 0.65 +/-0.03 0.75 +/-0.1 0.83 +/-0.02
QC 211 +/-12 200 +/-20 261 +/-17 127 +/-14 112 +/-7BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
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at earlier stages of development, in critical neurons that
modulate plasticity processes in motor neurons. While
this remains a formal possibility, it seems unlikely for
three reasons. First, our experiment with actin<raf<nlacZ
to visualize the history of GAL4 expression in C380 ani-
mals shows that it is quite stable and similar to the final
expression pattern seen in the third instar ventral ganglia
(Figure 1M,1N,1O,1P). Second, because GFP is a notori-
ously stable reporter molecule [28] we would expect even
biologically transient enhancer activity to be revealed by
stable reporter expression. Third, both OK6  and  C380
enhancers become active relatively late in embryogenesis
(Figure 1K and 2H) and their expression patterns in
embryos is highly similar to that observed in third-instar
larvae (data not shown).
A cell-autonomous function for AP1 in motor neurons is
also supported by two further lines of independent evi-
dence. First, expression of the same transgenes via the Cha
enhancer that identified CNS cholinergic neurons or post-
synaptic muscle enhancers, have no effect on motor syn-
apse plasticity. One possibility that the negative data for
the Cha enhancer reflects its low expression level is refuted
by its documented ability to drive dominant negative
transgenes at levels sufficient to induce a loss of function
phenotype for the highly expressed shibire  (dynamin)
gene [25,29]. Second, immunocytochemical analyses
(Figure 1) provide strong evidence for AP1 function in
motor neurons. Taken together, the data presented here
provide new and important evidence to support a model
in which AP1 regulates motor neuron plasticity through a
cell autonomous pathway.
Conclusions
Results presented here make the following points. 1. Fos
and Jun are expressed in Drosophila larval motor neurons;
this establishes that AP1 is appropriately localized for cell
autonomous function in motor synapse plasticity. 2.
Motor-neuron restricted expression of AP1 perturbing
transgenes via several alternative Gal4 drivers results in
previously described plasticity effects. 3. AP1 perturbation
outside of motor neurons has little effect on NMJ plastic-
ity. Together, these data substantially strengthen a model
in which AP1 acts in a cell autonomous pathway that reg-
ulates CREB-dependent and CREB-independent aspects of
NMJ plasticity [6,8].
Methods
Drosophila strains and culture conditions
Drosophila strains were cultured as previously described
[8,30]. The wild-type Oregon-R strain has been main-
tained in the Ramaswami lab. The UASFos, UASJun and
UASFBZ strains from Dr. Mariann Bienz have been previ-
ously characterized for roles in NMJ plasticity [8]. The
UASNlsGFP (encoding GFP tagged with a nuclear localiza-
tion signal) strain was from the Drosophila stock center
and the 2X-EGFP strain was from Haig Keshishian. Strains
with  C380, OK6, Cha  and MHC  enhancer driven Gal4
transgenes were from Vivian Budnik, Brian McCabe, Toshi
Kitamoto and Corey Goodman respectively. UAS-FLP is
from the Bloomington Stock Center and actin<raf<nLacZ
flies were obtained from Veronica Rodrigues and have
been described in [20].
Generating experimental and control animals
Males from transgenic (driver) lines expressing Gal4
under control of the various enhancers, were crossed to
virgin females from strains (responders) homozygous for
the following transgenes: UAS2XEGFP, UASNlsGFP, UAS-
FBZ, UASAP1 (UASFos;UASJun). Female larvae carrying
both the Gal4 and Gal4-responsive transgenes were ana-
lyzed. These were compared to female progeny from
crossing Gal4 driver males to wild-type Oregon R virgin
females.
Immunohistochemistry and confocal microscopy
For examining CNS expression larvae were dissected in
standard HL3 ringers and fixed in sodium phosphate
buffer containing 0.1% Triton X-100 and 4% paraformal-
dehyde for one hour at 4°C. Preparations were washed 3
times for 10 minutes each in phosphate buffer (0.1 M
Na2HPO4 and 0.1 M NaH2PO4) and incubated in appro-
priately diluted primary antibody overnight at 4°C. This
was followed by 6 washes of 10 minutes each with phos-
phate buffer and incubation in Alexa dye (Molecular
Probes, OR) conjugated secondary antibody for one hour
at room temperature. Finally, the preparations were
washed 6 times again in phosphate buffer, then once in
normal phosphate buffered saline (PBS) and mounted in
vectashield (Vector Labs.) on superfrost charged glass
slides (VWR) for confocal microscopy. Laser scanning
confocal microscopy was performed on a Nikon confocal
microscope. Maximum projections were generated from
stacks collected with a spacing of 1.5 µ in all cases. Images
were further processed for presentation using Adobe Pho-
toshop. Embryo histochemistry was according to standard
procedures as described in "Drosophila, A Laboratory
Manual" by Michael Ashburner, CSHL Press.
Retrograde nerve filling to identify motor neurons
Larvae were anesthetized by chilling on ice for 3 to 5 min-
utes, and then, they were pinned with dorsal side up on
Sylgard-coated (Dow Corning Co., Midland, MI) petri
dishes containing HL3 saline [31]. Larvae were dissected
along the dorsal midline. The gut, salivary glands, fat bod-
ies and trachea were removed. For retrograde labelling of
the motoneurons, one or both side nerve branches inner-
vating the fifth or sixth abdominal segment were isolated
in a petroleum jelly pool to allow the uptake of dye (5%
w/v rhodamine-dextran-3000 kD in distilled water;BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/20
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Molecular Probes, Eugene, OR.) [32]. The rhodamine-
dextran-labeled preparations were stored at room temper-
ature (RT) for a maximum of 1 hour, in the dark. Prepara-
tions were fixed in 2.5% formaldehyde, 3% sucrose, in
PBS, pH 7.3, for 2–5 hour, at RT, in the dark. The prepara-
tions were washed in PBS after fixation and mounted in
50% glycerol in PBS.
Electrophysiology, statistical analyses
Voltage clamp was performed as described previously
(Sanyal et al, 2002). Briefly, larvae were dissected in HL3
ringers. Both the voltage sensing (10–15 MΩ) and current
injecting (5–10 MΩ) were heat pulled fiber filled glass
capillaries. Excitatory evoked junctional currents (EJCs)
were recorded in the TEVC mode using an axoclamp-2B
amplifier. The holding potential was -70 mV for all
recordings. EJCs were recorded from muscle 6 in abdomi-
nal segment 2 following a supra-threshold stimulation to
the innervating motor axons at 1 Hz. Mean EJC amplitude
was determined by averaging 20 sequential EJCs. Sponta-
neous events were also monitored for a period of 50 sec-
onds. The mean mini-EJC (mEJC) amplitude was
calculated from these traces using the mini-analysis soft-
ware http://synaptosoft.com. Statistical analysis including
graphing and test of significance (paired t-tests) were per-
formed in Sigma Plot (Jandel Scientific). Quantal content
was calculated by dividing the mean EJC amplitude by the
mean mEJC amplitude.
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